195 related articles for article (PubMed ID: 7037661)
1. A comparative trial of timolol and flutonidin as antihypertensive agents.
Salvadeo A; Segagni S; Villa G; Galli F; Piazza W; Bovio G
Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):78-84. PubMed ID: 7037661
[TBL] [Abstract][Full Text] [Related]
2. Timolol and a hydrochlorothiazide-amiloride combination in the treatment of essential hypertension in young and middle-aged patients: a comparative study with once-daily administration.
Lindroos M; Lehtonen A
Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):643-5. PubMed ID: 6396239
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene.
Pörsti P; Jalonen K; Ryysy L; Toivonen T; Viherkoski M
Ann Clin Res; 1981 Feb; 13(1):6-10. PubMed ID: 7018363
[TBL] [Abstract][Full Text] [Related]
4. [Comparison between timolol maleate and alphamethyldopa in longterm treatment of essential hypertension (author's transl)].
G Ital Cardiol; 1981; 11(12):2110-6. PubMed ID: 7346307
[No Abstract] [Full Text] [Related]
5. Antihypertensive effect of oral timolol maleate and hydrochlorothiazide once daily compared with hydrochlorothiazide once daily.
Durley Y; Cubberley RB; Thomas S
Am J Hosp Pharm; 1981 Aug; 38(8):1161-4. PubMed ID: 7270561
[TBL] [Abstract][Full Text] [Related]
6. "Timolol in essential hypertension" a preliminary report.
Okuwobi B; Ogunyemi O
West Afr J Pharmacol Drug Res; 1977 Jun; 4(1):37-42. PubMed ID: 602178
[TBL] [Abstract][Full Text] [Related]
7. [Antihypertensive therapy with a new beta-blocking agent Timolol. Double blind study and comparison with Alprenolol and Pindolol (author's transl)].
Wessels F; Heinze A; Werth HW
Med Klin; 1977 Oct; 72(41):1689-95. PubMed ID: 335203
[TBL] [Abstract][Full Text] [Related]
8. [Hypotensive effects of timolol in 86 patients (author's transl)].
Lagrue G; Gumpelson A; Kazandjan M; Grillot A
Sem Hop; 1978 Oct 8-15; 54(29-32):929-32. PubMed ID: 216083
[TBL] [Abstract][Full Text] [Related]
9. [Monotherapy of hypertension with a beta-blocker in a single daily dose (author's transl)].
Gilgenkrantz JM; Languillat JM; Zannad F
Sem Hop; 1981 May 18-25; 57(19-20):985-7. PubMed ID: 6266030
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study.
Chiseliţă D; Antohi I; Medvichi R; Danielescu C
Oftalmologia; 2005; 49(3):39-45. PubMed ID: 16408674
[TBL] [Abstract][Full Text] [Related]
11. [New antihypertensive agent of the imidazoline series: 5-fluoro-methyl-imidazolidinylidene-benzamine-monohydrochloride (flutonidin)].
Brunner H; Djawan S; Dorda W; Penner E; Grabner G
Arzneimittelforschung; 1977; 27(8):1599-604. PubMed ID: 334188
[TBL] [Abstract][Full Text] [Related]
12. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.
Liu JH; Medeiros FA; Slight JR; Weinreb RN
Ophthalmology; 2009 Mar; 116(3):449-54. PubMed ID: 19157559
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
Barnebey HS; Orengo-Nania S; Flowers BE; Samples J; Mallick S; Landry TA; Bergamini MV
Am J Ophthalmol; 2005 Jul; 140(1):1-7. PubMed ID: 15990081
[TBL] [Abstract][Full Text] [Related]
14. A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components.
Diestelhorst M; Larsson LI;
Ophthalmology; 2006 Jan; 113(1):70-6. PubMed ID: 16263174
[TBL] [Abstract][Full Text] [Related]
15. [Long-term treatment with a new antihypertensive drug: flutonidin].
Nicrosini F; Pasotti C
Minerva Med; 1983 May; 74(21):1297-300. PubMed ID: 6406947
[TBL] [Abstract][Full Text] [Related]
16. Timolol/bendrofluazide combination ('Prestim') in the treatment of poorly controlled hypertensive patients in general practice.
Douglas-Jones AP
Pharmatherapeutica; 1984; 3(9):631-5. PubMed ID: 6728865
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
[TBL] [Abstract][Full Text] [Related]
18. [Antihypertensive effects of timolol and of the combination timolol, amiloride and hydrochlorothiazide].
Cospite M; Ferrara F; Raimondi F; Lo Presti T; Ballo M; Milio G; Meli F
Clin Ter; 1981 Sep; 98(6):617-26. PubMed ID: 7026143
[No Abstract] [Full Text] [Related]
19. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
20. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
